Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

What does Serum Glycosylated Apolipoprotein J mean in a heart attack?-----Correlation of serum glycosylated apolipoprotein J with acute myocardial infarction

Rao Yao, Mengmeng Ren, Haibin Dong, Hua Wang, Wenjuan Jia, Xiaoning Ding, Kaixuan Fu, Anyi Wang, Xuefeng Zhu, Lei Gong, Lin Zhong
doi: https://doi.org/10.1101/2023.06.19.23291631
Rao Yao
1The 2nd Medical College of Binzhou Medical University, Yantai, Shandong 264003, P.R. China
Roles: Master
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mengmeng Ren
2Department of Cardiology of the affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, Shandong 264000, P.R. China
Roles: Master
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Haibin Dong
2Department of Cardiology of the affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, Shandong 264000, P.R. China
Roles: Master
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hua Wang
2Department of Cardiology of the affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, Shandong 264000, P.R. China
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wenjuan Jia
2Department of Cardiology of the affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, Shandong 264000, P.R. China
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiaoning Ding
2Department of Cardiology of the affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, Shandong 264000, P.R. China
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kaixuan Fu
2Department of Cardiology of the affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, Shandong 264000, P.R. China
Roles: Master
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anyi Wang
2Department of Cardiology of the affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, Shandong 264000, P.R. China
Roles: Master
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xuefeng Zhu
2Department of Cardiology of the affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, Shandong 264000, P.R. China
Roles: Master
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lei Gong
2Department of Cardiology of the affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, Shandong 264000, P.R. China
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lin Zhong
2Department of Cardiology of the affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, Shandong 264000, P.R. China
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background There are few myocardial damage markers that could be used to diagnose acute myocardial infarction(AMI) or assess its severity, especially glycosylated apolipoprotein J(ApoJ-Glyc) has demonstrated superiority in cardiomyocytes and animal STEMI models in the early stages of myocardial ischemia(MI). We aimed to excavate the potential role of ApoJ-Glyc as a protein marker in the pathogenesis of AMI in humans and its added value in the evolution of the disease.

Methods and Results ELISA was used to determine the serum concentration of ApoJ-Glyc in 163 patients enrolled by the criteria. Statistical analysis could used to discuss the relationship between ApoJ-Glyc and AMI. Compared to control groups, serum ApoJ-Glyc levels decreased by 36% and 37% in early AMI patients and AMI patients, respectively (P<0.0001), showing a higher discriminant value for early diagnosis and diagnosis of AMI [area under the curve (AUC) : 0.871 and 0.886, P< 0.0001]. For the first time, we demonstrated that ApoJ-Glyc was not statistically significant in the comparative difference between NSTEMI and STEMI groups (P> 0.05). Patients with gradually declining ApoJ-Glyc had a higher Grace Risk Scores. Subsequent studies have also demonstrated that more MACCE did occur with a 6-month follow-up(P<0.05).

Conclusions ApoJ-Glyc which serve as an alarm bell for the detection of early ischaemia, may be a new biomarker for AMI. ApoJ-Glyc can assess the severity of myocardial infarction. The continuous decrease of serum ApoJ-Glyc suggests an increase in the risk of post-AMI ischaemia and the onset of unpredictable MACCE.

Figure
  • Download figure
  • Open in new tab

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was supported by National Natural Science Foundation of China (No.82200503), Key Research and Development Program of Shandong Province (No. 2019GSF108142)and National Natural Science Foundation of Shandong Province(No. ZR2020MH185 and ZR2022QH237)

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study was approved by Ethics Committee of Yantai Yuhuangding Hospital (NO.:2023-254; approved May 29, 2023; ?Correlation of serum glycosylated apolipoprotein J with acute myocardial infarction?). The study protocol conforms to the ethical standards of the responsible committee on human experimentation (institutional or regional) and the 1975 Declaration of Helsinki.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Footnotes

  • E-mail: Rao Yao1: yaoraohee{at}163.com, Mengmeng Ren2*: 17853589692{at}163.com, Haibin Dong2*:hbdong{at}126.com, Hua Wang2:ronghua201314{at}163.com, Wenjuan Jia2: jiawj15{at}163.com, Xiaoning Ding2:dingxiaoning{at}alumni.sjtu.edu.cn, Kaixuan Fu2: 1963363419{at}qq.com, Anyi Wang2: way297888553{at}163.com Lei Gong2*: gonglei27{at}163.com, Lin Zhong2*: zhonglin2019{at}163.com, Xuefeng Zhu2: zxflwj{at}126.com

Data Availability

The data underlying this article will be shared on reasonable request to the corresponding author.

  • Nonstandard Abbreviations and Acronyms

    ApoJ-Glyc
    glycosylated apolipoprotein J
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
    Back to top
    PreviousNext
    Posted June 20, 2023.
    Download PDF
    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    What does Serum Glycosylated Apolipoprotein J mean in a heart attack?-----Correlation of serum glycosylated apolipoprotein J with acute myocardial infarction
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    What does Serum Glycosylated Apolipoprotein J mean in a heart attack?-----Correlation of serum glycosylated apolipoprotein J with acute myocardial infarction
    Rao Yao, Mengmeng Ren, Haibin Dong, Hua Wang, Wenjuan Jia, Xiaoning Ding, Kaixuan Fu, Anyi Wang, Xuefeng Zhu, Lei Gong, Lin Zhong
    medRxiv 2023.06.19.23291631; doi: https://doi.org/10.1101/2023.06.19.23291631
    Twitter logo Facebook logo LinkedIn logo Mendeley logo
    Citation Tools
    What does Serum Glycosylated Apolipoprotein J mean in a heart attack?-----Correlation of serum glycosylated apolipoprotein J with acute myocardial infarction
    Rao Yao, Mengmeng Ren, Haibin Dong, Hua Wang, Wenjuan Jia, Xiaoning Ding, Kaixuan Fu, Anyi Wang, Xuefeng Zhu, Lei Gong, Lin Zhong
    medRxiv 2023.06.19.23291631; doi: https://doi.org/10.1101/2023.06.19.23291631

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Cardiovascular Medicine
    Subject Areas
    All Articles
    • Addiction Medicine (349)
    • Allergy and Immunology (668)
    • Allergy and Immunology (668)
    • Anesthesia (181)
    • Cardiovascular Medicine (2648)
    • Dentistry and Oral Medicine (316)
    • Dermatology (223)
    • Emergency Medicine (399)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
    • Epidemiology (12228)
    • Forensic Medicine (10)
    • Gastroenterology (759)
    • Genetic and Genomic Medicine (4103)
    • Geriatric Medicine (387)
    • Health Economics (680)
    • Health Informatics (2657)
    • Health Policy (1005)
    • Health Systems and Quality Improvement (985)
    • Hematology (363)
    • HIV/AIDS (851)
    • Infectious Diseases (except HIV/AIDS) (13695)
    • Intensive Care and Critical Care Medicine (797)
    • Medical Education (399)
    • Medical Ethics (109)
    • Nephrology (436)
    • Neurology (3882)
    • Nursing (209)
    • Nutrition (577)
    • Obstetrics and Gynecology (739)
    • Occupational and Environmental Health (695)
    • Oncology (2030)
    • Ophthalmology (585)
    • Orthopedics (240)
    • Otolaryngology (306)
    • Pain Medicine (250)
    • Palliative Medicine (75)
    • Pathology (473)
    • Pediatrics (1115)
    • Pharmacology and Therapeutics (466)
    • Primary Care Research (452)
    • Psychiatry and Clinical Psychology (3432)
    • Public and Global Health (6527)
    • Radiology and Imaging (1403)
    • Rehabilitation Medicine and Physical Therapy (814)
    • Respiratory Medicine (871)
    • Rheumatology (409)
    • Sexual and Reproductive Health (410)
    • Sports Medicine (342)
    • Surgery (448)
    • Toxicology (53)
    • Transplantation (185)
    • Urology (165)